Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate-to-severe psoriasis treated with guselkumab: 5-year data from VOYAGE 1

被引：0
|
作者：
Griffiths, Christopher E. M. [1 ]
Blauvelt, Andrew [2 ]
Han, Chenglong [3 ]
Fernandez-Penas, Pablo [4 ,5 ]
Adam, David N. [6 ,7 ]
Philipp, Sandra [8 ]
Song, Michael [9 ]
Miller, Megan [9 ]
You, Yin [9 ]
Langley, Richard G. [10 ]
机构：
[1] Univ Manchester, Salford Royal NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Dermatol Ctr, Manchester, Lancs, England
[2] Oregon Med Res Ctr, Portland, OR USA
[3] Janssen Global Serv LLC, Raritan, NJ USA
[4] Univ Sydney, Sydney, NSW, Australia
[5] Westmead Hosp, Westmead, NSW, Australia
[6] CCA Med Res Corp & Probity Med Res, Ajax, ON, Canada
[7] Prob Med Res, Waterloo, ON, Canada
[8] Charite Univ Med Berlin, Dept Dermatol, Berlin, Germany
[9] Janssen Res & Dev LLC, Raritan, NJ USA
[10] Dalhousie Univ, Halifax, NS, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27043
引用
收藏
页码：AB127 / AB127
页数：1
相关论文
共 50 条
  • [41] Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2
    Cork, Michael J.
    Eckert, Laurent
    Simpson, Eric L.
    Armstrong, April
    Barbarot, Sebastien
    Puig, Luis
    Girolomoni, Giampiero
    de Bruin-Weller, Marjolein
    Wollenberg, Andreas
    Kataoka, Yoko
    Remitz, Anita
    Beissert, Stefan
    Mastey, Vera
    Ardeleanu, Marius
    Chen, Zhen
    Gadkari, Abhijit
    Chao, Jingdong
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (06) : 606 - 614
  • [42] Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
    Strober, Bruce
    Greenberg, Jeffrey D.
    Karki, Chitra
    Mason, Marc
    Guo, Ning
    Hur, Peter
    Zhao, Yang
    Herrera, Vivian
    Lin, Feng
    Lebwohl, Mark
    BMJ OPEN, 2019, 9 (04):
  • [43] BIMEKIZUMAB SHOWS SUSTAINED LONG-TERM IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY
    Baraliakos, X.
    Dougados, M.
    Gaffney, K.
    Sengupta, R.
    Magrey, M.
    De Peyrecave, N.
    Oortgiesen, M.
    Vaux, T.
    Fleurinck, C.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 720 - 721
  • [44] Sustained improvement in skin disease-specific quality of life in patients with moderate to severe psoriasis receiving ustekinumab maintenance therapy: Long-term results from PHOENIX 1
    Leonardi, C.
    Kimball, A.
    Schenkel, B.
    Papp, K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB149 - AB149
  • [45] Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Kircik, Leon
    Schlesinger, Todd
    Pierce, Evangeline
    Burge, Russel
    Behling, Michael
    Atwater, Amber Reck
    Elmaraghy, Hany
    Armstrong, April
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [46] Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial
    Strand, Vibeke
    Mease, Philip
    Burmester, Gerd R.
    Nikai, Enkeleida
    Coteur, Geoffroy
    van Vollenhoven, Ronald
    Combe, Bernard
    Keystone, Edward C.
    Kavanaugh, Arthur
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)
  • [47] Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial
    Vibeke Strand
    Philip Mease
    Gerd R Burmester
    Enkeleida Nikaï
    Geoffroy Coteur
    Ronald van Vollenhoven
    Bernard Combe
    Edward C Keystone
    Arthur Kavanaugh
    Arthritis Research & Therapy, 11
  • [48] Impact of baricitinib on patient-reported skin symptoms, itch, and quality of life in adult patients with moderate to severe atopic dermatitis and an inadequate response to topical therapies from phase 3 trials BREEZE-AD1 and BREEZE-AD2
    Lio, Peter
    Nosbaum, Audrey
    Cardillo, Tracy
    DeLozier, Amy
    Gamalo, Margaret
    Ball, Susan G.
    Bieber, Thomas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB28 - AB28
  • [49] Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
    Gisondi, Paolo
    Gottlieb, Alice B. B.
    Elewski, Boni
    Augustin, Matthias
    McBride, Sandy
    Tsai, Tsen-Fang
    de la Loge, Christine
    Fierens, Frederik
    Lopez Pinto, Jose M.
    Tilt, Nicola
    Lebwohl, Mark
    DERMATOLOGY AND THERAPY, 2023, 13 (01) : 315 - 328
  • [50] Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
    Paolo Gisondi
    Alice B. Gottlieb
    Boni Elewski
    Matthias Augustin
    Sandy McBride
    Tsen-Fang Tsai
    Christine de la Loge
    Frederik Fierens
    José M. López Pinto
    Nicola Tilt
    Mark Lebwohl
    Dermatology and Therapy, 2023, 13 : 1389 - 1390
12345